Drugs/Approval·openFDA

Ultra Violette Sheen Screen Hydrating Lip Balm Last Bite Broad Spectrum SPF 50 — Grace and Fire USA Inc. drug label update

LowPublished May 1, 2026· AI-analyzed May 4, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Grace and Fire USA Inc. updated the drug labeling for Ultra Violette Sheen Screen Hydrating Lip Balm Last Bite Broad Spectrum SPF 50. The labeling includes indications for preventing sunburn and reducing the risk of skin cancer and early skin aging when used as directed.

Who it affects

Grace and Fire USA Inc., manufacturers of SPF-rated lip care products, and regulatory professionals managing OTC drug labeling.

Why it matters

This update indicates a formalized inclusion of broad-spectrum sun-protection claims for a lip balm product. Regulatory teams should note the specific phrasing regarding sun protection measures, which suggests the manufacturer is aligning with standardized OTC monograph requirements for sunscreens to claim skin cancer and aging risk reduction.

Practical takeaway

Regulatory and QA teams should ensure that all SPF-labeled lip products maintain internal documentation supporting broad spectrum claims and that labeling instructions for use are consistent with sun protection efficacy data.

FDA source material

Ultra Violette Sheen Screen Hydrating Lip Balm Last Bite Broad Spectrum SPF 50 (Grace and Fire USA Inc.). HELPS PREVENT SUNBURN if used as directed with other protection measures (see directions) decrease the risk of skin cancer and early skin aging caused by the sun

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.